Zero Basic Duty for 25 More Medicines for Supply under Patient
Assistance Programmes
[Customs
Notification No. 83 dated 31 October 2017]
In
exercise of the powers conferred by sub-section (1) of section 25 of the Customs
Act, 1962 (52 of 1962), the Central Government, on being satisfied that it is
necessary in the public interest so to do, hereby makes the following further
amendments in the notification of the Government of India, in the Ministry of
Finance (Department of Revenue), No. 16/2017-Customs, dated the 20th April,
2017, published in the Gazette of India, Extraordinary, Part II, Section 3,
Sub-section (i), vide number G.S.R.394 (E),
dated the 20th April, 2017, namely: -
In
the said notification, in the Table, after serial number 27 and the
entries relating thereto, the following serial numbers and entries shall be added,
namely: -
|
(1)
|
(2)
|
(3)
|
(4)
|
|
“28.
|
Erlotinib
(Tarceva) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
29
|
Trastuzumab
(Herclon) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
30.
|
Pertuzumab
(Perjeta) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
31.
|
Transtuzumab
Emtansine (Kadcyla) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
32.
|
Obinutuzumab
(Gazyva) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
33.
|
Bevacizumab
(Avastin) |
The
Blue Tree |
Roche
Products (India) Private Limited |
|
34.
|
Tocilizumab
(Actemra) |
Care
for Joints |
Roche
Products (India) Private Limited |
|
35.
|
Mycophenolate
Mofetil (CellCept) |
Aarambh
|
Roche
Products (India) Private Limited |
|
36.
|
Avonex
(Interferon Beta 1A) |
Reach
|
UCB
India Private Limited |
|
37.
|
Tysabri
(Monoclonal Antibody |
Reach
|
UCB
India Private Limited |
|
38.
|
Tecfidera
(Di- methyl Fumarate) |
Reach
|
UCB
India Private Limited |
|
39.
|
Plegridy
(Peggylated Interferon Beta 1A) |
Reach
|
UCB
India Private Limited |
|
40.
|
Sorafenib
(Nexavar) |
NexCSP
(Nexavar Cancer Survivorship Program) |
Bayer
Zydus Pharma Private
Limited |
|
41.
|
Sirturo
(Bedaquiline) |
Bedaquiline
Compassionate Use Program |
Janssen
India, Johnson & Johnson Private Limited |
|
42.
|
Darzalex
(Daratumumab) |
Daratumumab
Patient Assistance Program |
Janssen
India, Johnson & Johnson Private Limited |
|
43.
|
SUTENT
|
-
Patients initially pay for 12 strips (value equivalent of 50 mg) and gets
assistance of 12 strips free. - Post purchase of 12 strips patients receive
the drug free until prescribed by treating physicians. -Full subsidy for BPL
patients |
Pfizer
Products India Private Limited |
|
44.
|
CRIZALK
|
Patients
will pay for 8 bottles (either 200 mg or 250 mg) and post that will get the
drug free until prescribed by treating physician. - Full subsidy for BPL
patients |
Pfizer
Products India Private Limited |
|
45.
|
INLYTA
|
Sutent
Patients who progresses and prescribed lnlyta as
2nd line pays for 1 strip and gets 1 strip free. - Patients who progresses on
other 1st line TKI pays for 2 strips and get 1 strip free. -Ful1subsidy for
BPL patients |
Pfizer
Products India Private Limited |
|
46.
|
PALBACE
|
-Patients
will pay for 10 cycles and post that will get free drug support until
prescribed by treating physicians. - Full subsidy for BPL patients |
Pfizer
Products India Private Limited |
|
47.
|
ENBREL
|
ENLIVEN
-Enbrel 50 mg: 4+2PAP. Any further repeat purchase will be given at a further
discounted price -Enbrel25mg: 8+4 PAP. Any further repeat purchase will be
given at a further discounted price |
Pfizer
Limited |
|
48.
|
XELJANZ
|
XELSOURCE
India specific price of Rs. 24000 per bottle (MRP
is Rs. 66000 per bottle) |
Pfizer
Limited |
|
49.
|
GENPTROPIN
|
5+1
PAP |
Pfizer
Products India Private Limited |
|
50.
|
Atgam
|
For
AIIMS Delhi 5+1, KEM Mumbai 4+1, CMC Vellore 4+1 & Other hospitals 20+4 |
Pfizer
Products India Private Limited |
|
51.
|
Aromasin
|
PAP
1+1 |
Pfizer
Products India Private Limited |
|
52.
|
Campto
|
PAP
1+1 |
Pfizer
Products India Private Limited”. |
[F.
No. 332/24/2010-TRU (Pt. I)]